Company news
Aptevo Therapeutics Inc. news in 2023
Aptevo Therapeutics Inc.'s news releases, calls and decks from 2023, newest first.
Aptevo Therapeutics Reports 3Q23 Financial Results and Provides a Business Update
November 13, 2023
Aptevo Therapeutics Reports 2Q23 Financial Results and Provides a Business Update
August 9, 2023
Aptevo Therapeutics Inc. Announces Closing of Previously Announced $5 Million Public Offering
August 3, 2023
Aptevo Therapeutics Inc. Announces Pricing of $5 Million Public Offering
July 31, 2023
Aptevo Announces Positive Duration of Remission Data from Phase 1b Expansion Trial Evaluating the Bispecific APVO436 for AML
July 17, 2023
Aptevo Therapeutics Reports 1Q23 Financial Results and Provides Business Update
May 10, 2023
Aptevo Therapeutics Reports 2022 Financial Results and Provides Business Update
March 29, 2023
Aptevo Therapeutics Raises $9.6 Million in Non-Dilutive Funding
March 29, 2023
Aptevo Therapeutics Files Provisional Patent for Fifth Bispecific Antibody APVO711, Intended for the Treatment of Solid Tumors
January 8, 2023